Metraipolis › archive › dc_5d84aa1bbd3e

Screening of Medicines for Malaria Venture Open Boxes Identifies Potent SARS-CoV‑2 Papain-like Protease (PLpro) Inhibitors — Europe PMC PMID:41018631

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41018631
DOI
10.1021/acsomega.5c04858
License (as archived)
solo-consultazione
Archived
2026-11-10T00:24:06.151Z
SHA-256 of the archived text
216abc098166bdb79197e424fd57c01a86dd70b7dc43ab37269be468940a2f9e
Stable URL of this page
https://metraipolis.com/documento/dc_5d84aa1bbd3e

How to cite

Screening of Medicines for Malaria Venture Open Boxes Identifies Potent SARS-CoV‑2 Papain-like Protease (PLpro) Inhibitors — Europe PMC PMID:41018631 — Europe PMC (en), https://europepmc.org/article/MED/41018631 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5d84aa1bbd3e (Metraipolis archive dc_5d84aa1bbd3e, sha256 216abc098166bdb79197e424fd57c01a86dd70b7dc43ab37269be468940a2f9e)
BibTeX
@misc{dc5d84aa1bbd3e,
  title = {Screening of Medicines for Malaria Venture Open Boxes Identifies Potent SARS-CoV‑2 Papain-like Protease (PLpro) Inhibitors — Europe PMC PMID:41018631},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41018631},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5d84aa1bbd3e; sha256 216abc098166bdb79197e424fd57c01a86dd70b7dc43ab37269be468940a2f9e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41018631. Agents can read the archived copy with the MCP tool read_document.